Chronic obstructive pulmonary disease (COPD) is a common, complex, and heterogeneous
disorder that is responsible for substantial and growing morbidity, mortality, and health-care …

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is
characterized by persistent airflow limitation with several features usually associated with …

Background Asthma-COPD overlap syndrome (ACOS) has been described and
acknowledged as a distinct clinical entity; however, its characteristics in daily clinical …

The presence of eosinophilic inflammation is a characteristic feature of chronic and acute
inflammation in asthma. An estimated 5%–10% of the 300 million people worldwide who …

The term asthma-COPD overlap (ACO) has been used to identify a heterogeneous condition
in which patients present with airflow limitation that is not completely reversible and clinical …

Background Childhood asthma is strongly influenced by genetics and is a risk factor for
reduced lung function and chronic obstructive pulmonary disease (COPD) in adults. This …

Introduction: Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) is a
disease phenotype that shares T helper lymphocyte cell Th1/neutrophilic/non-Type-2 …

Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …

According to the current clinical practice guidelines for chronic obstructive pulmonary
disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β 2 agonist …

Asthma-COPD overlap (ACO) has been under intensive focus; however, the levels of
damage-associated molecular patterns (DAMPs) that can activate the innate and adaptive …